Publications by authors named "Veronica Diaz-Diaz"
Purpose: To evaluate the efficacy and toxicity of Iridium-192 high-dose-rate endobronchial brachytherapy (HDR-EBT) for palliation of symptoms and for curative intent.
Material And Methods: This is a retrospective study of a prospectively registered cohort of 31 patients with endobronchial lesions treated with HDR-EBT at our institution between 2008 and 2020. Eighteen patients were treated with palliative intent and 13 curative intent; 4 of them as a boost to external radiation therapy (XRT).
Article Synopsis
- - Patients with unresectable stage III non-small-cell lung cancer face varied treatment options based on disease severity and other health issues, but traditional chemotherapy and radiotherapy have not significantly improved survival rates.
- - The article discusses recent advancements in molecular biology and radiation technology that have led to better patient outcomes and presents the current standard treatments for these advanced lung cancers.
- - New therapeutic strategies focus on both radical treatments and supportive care to enhance the quality of life for patients, reflecting the importance of personalized treatment plans in managing this challenging condition.
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Rep Pract Oncol Radiother
March 2020
Background: The optimal induction treatment in potentially-resectable stage IIIA-N2 NSCLC remains undefined.
Aim: To compare neoadjuvant high-dose chemoradiotherapy (CRT) to neoadjuvant chemotherapy (CHT) in patients with resectable, stage IIIA-N2 non-small-cell lung cancer (NSCLC).
Methods: Retrospective, multicentre study of 99 patients diagnosed with stage cT1-T3N2M0 NSCLC who underwent neoadjuvant treatment (high-dose CRT or CHT) followed by surgery between January 2005 and December 2014.